GFS Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-8,420
| Closed | -$458K | – | 141 |
|
2022
Q2 | $458K | Sell |
8,420
-528
| -6% | -$28.7K | 0.1% | 107 |
|
2022
Q1 | $487K | Sell |
8,948
-800
| -8% | -$43.5K | 0.1% | 122 |
|
2021
Q4 | $537K | Buy |
9,748
+920
| +10% | +$50.7K | 0.09% | 126 |
|
2021
Q3 | $422K | Hold |
8,828
| – | – | 0.09% | 127 |
|
2021
Q2 | $439K | Hold |
8,828
| – | – | 0.1% | 113 |
|
2021
Q1 | $394K | Hold |
8,828
| – | – | 0.09% | 110 |
|
2020
Q4 | $406K | Hold |
8,828
| – | – | 0.11% | 102 |
|
2020
Q3 | $415K | Hold |
8,828
| – | – | 0.13% | 90 |
|
2020
Q2 | $450K | Hold |
8,828
| – | – | 0.14% | 87 |
|
2020
Q1 | $418K | Buy |
8,828
+280
| +3% | +$13.3K | 0.13% | 84 |
|
2019
Q4 | $502K | Hold |
8,548
| – | – | 0.13% | 90 |
|
2019
Q3 | $456K | Sell |
8,548
-8,064
| -49% | -$430K | 0.13% | 91 |
|
2019
Q2 | $831K | Hold |
16,612
| – | – | 0.24% | 75 |
|
2019
Q1 | $868K | Sell |
16,612
-1,120
| -6% | -$58.5K | 0.26% | 74 |
|
2018
Q4 | $847K | Sell |
17,732
-5
| -0% | -$239 | 0.23% | 74 |
|
2018
Q3 | $891K | Sell |
17,737
-4,385
| -20% | -$220K | 0.23% | 79 |
|
2018
Q2 | $1.12M | Sell |
22,122
-2,560
| -10% | -$129K | 0.23% | 79 |
|
2018
Q1 | $1.21M | Buy |
24,682
+2,732
| +12% | +$133K | 0.25% | 75 |
|
2017
Q4 | $974K | Buy |
21,950
+8,508
| +63% | +$378K | 0.21% | 85 |
|
2017
Q3 | $682K | Sell |
13,442
-53
| -0.4% | -$2.69K | 0.15% | 96 |
|
2017
Q2 | $727K | Buy |
13,495
+4,800
| +55% | +$259K | 0.16% | 98 |
|
2017
Q1 | $458K | Buy |
8,695
+4,458
| +105% | +$235K | 0.09% | 117 |
|
2016
Q4 | $204K | Hold |
4,237
| – | – | 0.04% | 136 |
|
2016
Q3 | $228K | Buy |
+4,237
| New | +$228K | 0.05% | 129 |
|
2016
Q2 | – | Sell |
-4,237
| Closed | -$215K | – | 134 |
|
2016
Q1 | $215K | Sell |
4,237
-1,720
| -29% | -$87.3K | 0.06% | 127 |
|
2015
Q4 | $300K | Buy |
5,957
+1,440
| +32% | +$72.5K | 0.09% | 118 |
|
2015
Q3 | $217K | Buy |
+4,517
| New | +$217K | 0.08% | 116 |
|